Loading...
Neoadjuvant treatment for resectable pancreatic adenocarcinoma
Pancreatic adenocarcinoma is the fourth leading cause of cancer mortality in the United States in both men and women, with a 5-year survival rate of less than 5%. Surgical resection remains the only curative treatment, but most patients develop systemic recurrence within 2 years of surgery. Adjuvant...
Na minha lista:
| Udgivet i: | World J Clin Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734931/ https://ncbi.nlm.nih.gov/pubmed/26862486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v7.i1.1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|